S&P 500 Financials Sector SEC Filings — February 11, 2026

11-02-2026

Enzon Pharmaceuticals, Inc. filed an 8-K on February 11, 2026, reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), indicating results from a shareholder meeting, and Item 9.01 (Financial Statements and Exhibits), which attaches relevant documents. No specific details on proposals voted upon, vote outcomes, or exhibit contents are disclosed. This is a multi-item, mandatory filing with no quantitative financial metrics, changes, or directional impacts provided.

11-02-2026

Darling Ingredients Inc. filed an 8-K on February 11, 2026 (AccNo: 0000916540-26-000004), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but no specific revenue, earnings, margins, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period changes, or segment details are mentioned.

11-02-2026

Getty Realty Corp filed an 8-K on February 11, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits. No specific revenue, earnings, balance sheet metrics, period-over-period changes, or quantitative financial data are explicitly stated in the provided filing information. This appears to be a standard earnings-related disclosure without detailed metrics available.

12-02-2026

ARTIVION, INC. filed a Form 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This is a standard voluntary earnings-related disclosure without performance data available for analysis.

• ·AccNo: 0001628280-26-007674
• ·Filing size: 698 KB
• ·Event Type: Financial Results
• ·Source: us_sec

12-02-2026

SOLV Energy, Inc. filed a multi-item Form 8-K on 2026-02-12 reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departures or elections of directors/officers including compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws and/or change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative transaction values, financial impacts, share counts, or performance metrics are disclosed. The filing covers both potentially strategic developments and governance/equity changes with unknown directional implications.

12-02-2026

Coinbase Global, Inc. filed an 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results and attaches relevant exhibits, but no specific revenue, earnings, guidance, or other metrics are detailed in the provided information. No positive or negative performance indicators, period-over-period changes, or strategic details are mentioned.

12-02-2026

Radian Group Inc filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048971), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for the change, or any quantitative data are explicitly stated. No positive or negative metrics, financial impacts, or governance implications are provided in the available information.

12-02-2026

Diodes Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048964), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing related to financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are mentioned. No positive or negative performance details, period-over-period comparisons, or forward-looking statements are provided in the filing information.

12-02-2026

Karyopharm Therapeutics Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001193125-26-047670), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for earnings announcements, but no specific revenue, earnings, balance sheet details, period-over-period comparisons, or other quantitative metrics are disclosed in the provided summary. No positive or negative financial changes can be assessed due to lack of data.

• ·Filing size: 550 KB
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

12-02-2026

Curtiss Wright Corp filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007480), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings release disclosure without detailed quantitative data available.

11-02-2026

12-02-2026

Zebra Technologies Corp filed an 8-K on February 12, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but specific revenue, earnings, guidance, or other metrics are NOT_DISCLOSED. No positive or negative performance details, period-over-period comparisons, or transaction values are provided in the filing summary.

12-02-2026

West Pharmaceutical Services Inc filed an 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure of financial results, but specific revenue, earnings, guidance, or period-over-period metrics are NOT_DISCLOSED in the provided information. No positive or negative financial impacts, balance sheet changes, or operational details are available.

12-02-2026

Baxter International Inc. filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007474), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including the officer's name, position, reason for change, timing, financial metrics, or quantitative data are NOT_DISCLOSED. No positive or negative performance metrics, period-over-period comparisons, or scheduled events are mentioned.

• ·Filing size: 1 MB
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

12-02-2026

Sphere Entertainment Co. filed an 8-K on February 12, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or material events with dollar values are mentioned.

12-02-2026

Pilgrim's Pride Corp filed a Form 8-K on February 12, 2026 (AccNo: 0000802481-26-000007), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing focused on financial results disclosure. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are disclosed in the provided filing information.

12-02-2026

InMed Pharmaceuticals Inc. filed an 8-K on February 12, 2026 (AccNo: 0001062993-26-000819, Size: 396 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure likely including material non-public information and attached exhibits. No financial metrics, transactions, period-over-period changes, or quantitative data are explicitly stated in the filing summary.

12-02-2026

ONITY GROUP INC. filed a Form 8-K on February 12, 2026 (AccNo: 0001493152-26-006291), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, guidance, or other financial metrics are disclosed in the provided filing information. This is a multi-item filing likely announcing financial results with attached exhibits.

12-02-2026

Utz Brands, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001628280-26-007457), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing is typical for earnings releases but contains no specific revenue, earnings, guidance, or other quantitative metrics in the provided description. No positive or negative performance indicators, period-over-period changes, or financial impacts are disclosed.

12-02-2026

Federal Home Loan Mortgage Corp filed an 8-K on February 12, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, with Financial Statements and Exhibits provided under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were detailed in the provided filing information. This is a standard voluntary disclosure for financial results.

12-02-2026

Zoetis Inc. filed a Form 8-K on 2026-02-12 (AccNo: 0001555280-26-000008) under Item 2.02 reporting results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure without detailed metrics available for analysis.

12-02-2026

Affiliated Managers Group, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001628280-26-007464), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing pertains to financial results disclosure, likely including a press release or earnings details as exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are explicitly stated in the provided filing information.

12-02-2026

Corsair Gaming, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048668), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.

12-02-2026

Intelligent Bio Solutions Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001493152-26-006317), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or quantitative financial data were disclosed in the provided filing description. This is a multi-item filing focused on financial results disclosure.

12-02-2026

Expedia Group, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001324424-26-000005, Size: 1 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results and related exhibits, but no specific revenue, earnings, guidance, or other quantitative metrics are provided or mentioned. No positive or negative performance indicators, period-over-period changes, or forward-looking statements are disclosed.

12-02-2026

Twilio Inc filed a Form 8-K on February 12, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. This is a standard voluntary earnings-related disclosure with no specific revenue, earnings, guidance, or other quantitative metrics provided in the filing details. No positive or negative performance indicators, period-over-period comparisons, or material financial impacts are disclosed.

12-02-2026

Yelp Inc filed a Form 8-K on February 12, 2026 (AccNo: 0001345016-26-000011, Size: 5 MB), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period metrics are disclosed in the provided filing details. This is a standard multi-item filing for financial results announcement with no quantitative data available.

• ·AccNo: 0001345016-26-000011
• ·File Size: 5 MB
• ·Sector: not specified

12-02-2026

Canadian Pacific Kansas City Ltd filed a Form 8-K on February 12, 2026 (AccNo: 0001193125-26-048127, Size: 193 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, transaction values, financial metrics, or exhibit contents are disclosed. This appears to be a multi-item informational filing with no quantified positive or negative impacts mentioned.

• ·Accession Number: 0001193125-26-048127

12-02-2026

LIVE VENTURES Inc filed an 8-K on February 12, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard disclosure for financial results with exhibits attached.

12-02-2026

Momentus Inc. filed an 8-K on February 12, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders. No details on the specific matters, vote outcomes, or any numerical results such as shares voted, for/against, or abstentions are disclosed. This appears to be a single-item, mandatory disclosure typically related to shareholder meeting results.

12-02-2026

BGC Group, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007499, Size: 1 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing details. This represents a standard voluntary earnings-related disclosure without quantified financial impacts.

12-02-2026

Iron Mountain Inc filed a Form 8-K on February 12, 2026 (AccNo: 0001020569-26-000009, Size: 15 MB), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned in the provided filing details. This is a standard earnings-related disclosure with no quantitative performance data available.

11-02-2026

11-02-2026

Newmarket Corp filed an 8-K on February 11, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing details. This is an informational earnings-related disclosure with no quantitative metrics available.

12-02-2026

PG&E Corp filed an 8-K on February 12, 2026 (AccNo: 0001004980-26-000008), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific quantitative metrics, period-over-period comparisons, guidance, or other numerical data in the available description. No positive or negative performance indicators are detailed.

11-02-2026

HomeTrust Bancshares, Inc. filed an 8-K on February 11, 2026, reporting under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals involved, effective dates, or compensatory terms are disclosed. No financial metrics, quantitative impacts, or other changes are mentioned.

11-02-2026

AMERICAN REBEL HOLDINGS INC filed an 8-K on 2026-02-11 under Items 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing signals a core delisting event alongside equity sales and disclosures, with no quantitative financial metrics, transaction values, or performance comparisons disclosed. No positive or offsetting metrics are mentioned.

11-02-2026

Ondas Holdings Inc. filed an 8-K on February 11, 2026, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a voluntary disclosure likely sharing material non-public information with exhibits attached, but no specific details, financial metrics, transactions, or events are provided in the filing metadata. No quantitative data or performance metrics are disclosed.

11-02-2026

Brag House Holdings, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001213900-26-015027), disclosing information under Item 5.02 regarding departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or terms were provided in the filing summary. Sector not specified.

11-02-2026

RE/MAX Holdings, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001104659-26-013546, Size: 185 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for the change, and any financial or compensatory terms are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or governance impacts were provided in the available information.

11-02-2026

Peapack Gladstone Financial Corp filed an 8-K on February 11, 2026, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

11-02-2026

PLUG POWER INC filed a Form 8-K on February 11, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This is a multi-item filing with no quantitative data or directional impacts mentioned.

11-02-2026

NovoCure Ltd filed an 8-K on February 11, 2026 (AccNo: 0001645113-26-000010, Size: 183 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of material information with attached exhibits. No financial metrics, transactions, or performance data are specified.

11-02-2026

Aqua Metals, Inc. filed an 8-K on February 11, 2026, reporting entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also discloses other events (Item 8.01) and provides financial statements and exhibits (Item 9.01). No quantitative metrics, deal terms, parties, or performance impacts—positive or negative—are disclosed.

11-02-2026

CMS Energy Corp filed a Form 8-K on February 11, 2026 (AccNo: 0001104659-26-013521, Size: 328 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely including attached exhibits, but no specific details on the events, transactions, financials, or exhibits are disclosed. No quantitative metrics, guidance, or directional impacts are provided.

11-02-2026

Qorvo, Inc. filed an 8-K on February 11, 2026 (AccNo: 0000950103-26-001983), reporting under Item 5.07: Submission of Matters to a Vote of Security Holders. No specific matters submitted for vote, vote outcomes, tally details, or other numerical results are disclosed. This is purely informational with no financial metrics, changes, or directional implications provided.

11-02-2026

Skyworks Solutions, Inc. filed an 8-K on February 11, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. This mandatory disclosure details the outcome of matters voted on by shareholders at a meeting, such as director elections or proposals. No specific proposals, vote counts, percentages, or outcomes are disclosed in the provided filing information.

11-02-2026

Energy Vault Holdings, Inc. filed an 8-K on February 11, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. This is a multi-item filing announcing financial results with no specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics provided in the filing details. No positive or negative financial performance data is available.

11-02-2026

Sysco Corp filed an 8-K on February 11, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No core event details, financial metrics, transactions, or directional impacts are specified in the filing summary. Critical content such as the nature of 'Other Events' or attached exhibits remains undisclosed.

11-02-2026

Protalix BioTherapeutics, Inc. filed a Form 8-K on February 11, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing providing voluntary disclosure of information pursuant to Regulation FD, with supporting exhibits attached. No specific core events, financial metrics, transactions, or quantitative data are explicitly stated in the filing summary.

11-02-2026

Ernexa Therapeutics Inc. filed an 8-K on February 11, 2026 (AccNo: 0001493152-26-006227), reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details provided on the agreement, events, transaction value, financial impacts, or metrics. No positive, negative, or flat performance metrics are disclosed.

11-02-2026

PMGC Holdings Inc. filed an 8-K on February 11, 2026 (AccNo: 0001213900-26-015003, Size: 212 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the attached exhibits are provided. No financial metrics, transactions, or performance data are disclosed.

11-02-2026

Biogen Inc. filed a Form 8-K on 2026-02-11 disclosing an unspecified officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

11-02-2026

Galecto, Inc. filed a Form 8-K on February 11, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits, likely related to the agreement. No specific terms, transaction values, financial impacts, or quantitative metrics are provided in the filing summary.

11-02-2026

AST SpaceMobile, Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001493152-26-006223), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This multi-item filing pertains to financial results disclosure. No specific revenue, earnings, balance sheet impacts, guidance, or quantitative metrics are disclosed in the provided information.

11-02-2026

Auburn National Bancorporation, Inc. filed a Form 8-K on February 11, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). The filing is a multi-item disclosure, likely voluntary for Item 8.01, with no specific details on the events, transactions, financial impacts, or exhibits provided in the available information. No quantitative metrics, positive or negative changes, or material events are disclosed.

11-02-2026

STRATA Skin Sciences, Inc. filed a Form 8-K on 2026-02-11 disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 8.01 reports Other Events. No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed.

11-02-2026

Evolution Petroleum Corp filed an 8-K on February 11, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No transaction details, financial metrics, dollar values, or impacts are disclosed.

• ·AccNo: 0001104659-26-013485
• ·File Size: 550 KB

11-02-2026

Outlook Therapeutics, Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001104659-26-013470), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely including voluntary disclosure of an unspecified event with attached exhibits. No financial metrics, transaction details, quantitative data, positive or negative changes, or other specifics are disclosed.

11-02-2026

Granite Point Mortgage Trust Inc. filed an 8-K on February 11, 2026, disclosing Results of Operations and Financial Condition under Item 2.02. Financial Statements and Exhibits are provided under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed.

11-02-2026

Tronox Holdings plc filed an 8-K on February 11, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 covers other events and Item 9.01 lists financial statements and exhibits. Specific details including officer names, positions, reasons for change, or any quantitative data are NOT_DISCLOSED.

11-02-2026

Community Financial System, Inc. filed an 8-K on February 11, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative impacts are disclosed.

11-02-2026

Colombier Acquisition Corp. III filed an 8-K on February 11, 2026 (AccNo: 0001213900-26-014983) under Item 8.01 Other Events, related to a merger/acquisition event. Item 9.01 discloses financial statements and exhibits. No specific deal structure, parties, valuation, financial metrics, or quantitative data are provided in the filing summary.

11-02-2026

GCI Liberty, Inc. filed an 8-K on February 11, 2026, disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but no specific revenue, earnings, margins, comparisons, or guidance metrics are disclosed in the provided information. No positive or negative performance indicators, period-over-period changes, or quantitative impacts are mentioned.

11-02-2026

Cencora, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001104659-26-013465, size: 608 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely involving disclosure of material non-public information and other events, with exhibits attached. No specific details on events, transactions, financial metrics, positive or negative changes, or quantitative data are disclosed in the provided filing information.

11-02-2026

Horizon Technology Finance Corp filed an 8-K on February 11, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial impacts, or quantitative metrics are provided in the filing summary. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

11-02-2026

USANA Health Sciences Inc filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, timing, or quantitative data are disclosed.

11-02-2026

MARZETTI CO filed an 8-K on February 11, 2026, disclosing changes related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02. Other events are reported under Item 8.01, with financial statements and exhibits under Item 9.01. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics are disclosed.

11-02-2026

MID PENN BANCORP INC filed an 8-K on February 11, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, transaction values, financial impacts, or exhibits are provided in the filing summary. No quantitative metrics, positive or negative changes, or strategic implications are mentioned.

11-02-2026

La Rosa Holdings Corp. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics are disclosed.

11-02-2026

Aeluma, Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001213900-26-014960, Size: 320 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure of financial results, but no specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators are available.

11-02-2026

Portillo's Inc. filed an 8-K on 2026-02-11 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer's name, title, whether it is an appointment or resignation, reasons for the change, or any quantitative compensation data are disclosed. The filing appears routine with no mentioned positive or negative performance metrics tied to the change.

11-02-2026

Group 1 Automotive Inc filed an 8-K on February 11, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other event, transaction values, financial metrics, or exhibits are disclosed in the provided filing information.

11-02-2026

MSA Safety Inc filed an 8-K on February 11, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative metrics are mentioned in the filing summary. This appears to be a standard earnings-related disclosure with attached financial statements.

11-02-2026

Anterix Inc. filed an 8-K on 2026-02-11 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or quantitative metrics are mentioned in the filing summary. This multi-item filing provides informational disclosure on periodic financial results without detailed data.

11-02-2026

Noble Corp plc filed an 8-K on February 11, 2026 (AccNo: 0001895262-26-000073), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, or other quantitative metrics are provided in the filing summary. No positive or negative performance indicators are detailed.

11-02-2026

Watts Water Technologies Inc filed an 8-K on February 11, 2026 (AccNo: 0001104659-26-013437), reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a standard disclosure for financial results with attached exhibits, likely including an earnings press release. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.

• ·File size: 1 MB
• ·Event Type: Financial Results
• ·Sector: not specified

11-02-2026

Victory Capital Holdings, Inc. filed an 8-K on February 11, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, or exhibits are disclosed in the provided filing summary. This is an informational filing with no quantified metrics, transactions, or impacts mentioned.

11-02-2026

WesBanco Inc filed a Form 8-K on February 11, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing likely including attached materials such as a press release or presentation given the 27 MB file size. No specific financial metrics, transactions, guidance, or events are disclosed in the provided filing information.

11-02-2026

AAR CORP filed an 8-K on February 11, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also covers Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on positions affected, names, reasons for change, quantitative data, or performance metrics are disclosed.

11-02-2026

Navan, Inc. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, appointment or resignation status, reasons, or any quantitative data are NOT_DISCLOSED.

11-02-2026

Cipher Mining Inc. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with no specific details on position, individual, or reasons provided. The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No quantitative metrics, performance comparisons, or further context on the change's implications are disclosed.

11-02-2026

Antero Resources Corp filed an 8-K on February 11, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits likely containing press release or tables.

11-02-2026

Antero Midstream Corp filed a Form 8-K on February 11, 2026 (AccNo: 0001104659-26-013423), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This disclosure pertains to financial results, but specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are NOT_DISCLOSED. No positive or negative metrics, scheduled events, or transactions are detailed in the provided filing information.

11-02-2026

Leggett & Platt Inc filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-046691), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for an earnings release. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information.

11-02-2026

Integrated Biopharma Inc filed an 8-K on February 11, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but no specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance were detailed in the provided filing information. No positive or negative metrics disclosed.

11-02-2026

Customers Bancorp, Inc. filed a Form 8-K on February 11, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transaction values, financial metrics, or exhibit contents are disclosed in the filing summary. This appears to be a multi-item informational filing with no quantified positive or negative impacts mentioned.

11-02-2026

Evergy, Inc. filed a Form 8-K on 2026-02-11 reporting entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), and creation of a direct financial obligation or an obligation under an off-balance sheet arrangement (Item 2.03), with financial statements and exhibits attached (Item 9.01). No specific details, dollar values, parties, or impacts are disclosed. This multi-item filing signals changes in agreements and obligations, but lacks quantitative data for assessment.

11-02-2026

AllianceBernstein Holding L.P. filed an 8-K on February 11, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the content of the disclosure or exhibits provided in the summary. No financial metrics, transactions, or directional impacts are disclosed.

11-02-2026

Ameren Corp filed a Form 8-K on February 11, 2026 (AccNo: 0001002910-26-000005, Size: 785 KB), reporting Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing typical for earnings announcements, but no specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided information. No positive, negative, or flat performance indicators are mentioned.

11-02-2026

Elite Pharmaceuticals Inc. /NV/ filed an 8-K on February 11, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the filing summary provided. This is a multi-item informational filing likely including exhibits such as a press release.

11-02-2026

Richmond Mutual Bancorporation, Inc. filed an 8-K on February 11, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the provided filing information. This appears to be a voluntary disclosure with attached exhibits.

11-02-2026

BankUnited, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001504008-26-000008, Size: 1 MB) reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific financial metrics, transactions, or performance data disclosed in the provided filing summary. No positive or negative metrics are mentioned.

11-02-2026

Inspire Medical Systems, Inc. filed an 8-K on February 11, 2026, under Items 2.02 (Results of Operations and Financial Condition), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results alongside governance changes, but no specific metrics, transaction values, or performance details are provided in the filing summary. No positive or negative financial changes can be assessed due to lack of disclosed data.

11-02-2026

Equinix Inc filed an 8-K on February 11, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other events or the nature of the exhibits are disclosed in the provided filing summary. This is a multi-item filing with limited informational content available.

• ·Multi-item 8-K filing (Items 8.01 and 9.01)
• ·Filing date: 2026-02-11
• ·Accession Number: 0001101239-26-000033
• ·File size: 693 KB

11-02-2026

Seacoast Banking Corp of Florida filed an 8-K on February 11, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary. This appears to be an informational filing with attached exhibits, but content is NOT_DISCLOSED.

11-02-2026

Cognex Corp filed an 8-K on February 11, 2026, disclosing results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing announcing financial results, but specific revenue, earnings, margins, guidance, or performance metrics are NOT_DISCLOSED. No positive or negative changes, period-over-period comparisons, or strategic details are provided in the filing excerpt.

11-02-2026

Glacier Bancorp, Inc. filed an 8-K on February 11, 2026 (AccNo: 0000868671-26-000013, Size: 5 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing indicates a voluntary disclosure of potentially material non-public information with attached exhibits, such as press releases or presentations. No specific financial metrics, transactions, guidance, or events are detailed in the provided filing summary.

11-02-2026

Franklin BSP Realty Trust, Inc. filed an 8-K on February 11, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition and under Item 9.01 providing Financial Statements and Exhibits. This multi-item filing appears to be a standard earnings release announcement. No specific revenue, earnings, balance sheet changes, guidance, or quantitative metrics are disclosed in the provided filing summary.

11-02-2026

Aptiv PLC filed a Form 8-K on February 11, 2026, under Item 8.01 reporting Other Events. No specific details regarding the core event, financial impacts, transactions, metrics, or quantitative data are disclosed in the provided filing information. This appears to be a single-item voluntary disclosure.

11-02-2026

Tyler Technologies Inc filed an 8-K on February 11, 2026 (AccNo: 0000860731-26-000013), under Item 2.02 disclosing results of operations and financial condition as part of its financial results announcement. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided filing details. Sector is not specified.

11-02-2026

PennyMac Financial Services, Inc. filed an 8-K on February 11, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This appears to be a multi-item filing involving voluntary disclosure of material information under Regulation FD, with attached exhibits. No specific financial metrics, transactions, events, or quantitative data are detailed in the provided filing summary.

11-02-2026

Four Corners Property Trust, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-046680), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing typical for earnings releases, but no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were provided in the filing description. No positive or negative financial metrics were disclosed.

11-02-2026

ZYNEX INC filed an 8-K on 2026-02-11 (AccNo: 0001104659-26-013411) disclosing a bankruptcy or receivership event under Item 1.03. No additional details on the type of proceedings, financial impacts, debts, assets, or restructuring plans are provided in the filing summary. This event represents a material adverse development with no counterbalancing positive metrics mentioned.

11-02-2026

Primerica, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-046650), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing announces financial results but provides no specific revenue, earnings, margins, or other quantitative metrics in the available details. No period-over-period comparisons, guidance, or balance sheet impacts are detailed.

11-02-2026

BIO-TECHNE Corp filed an 8-K on 2026-02-11 disclosing an officer change or related matter under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the key position affected, individual names, appointment/resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

11-02-2026

COMMUNITY HEALTH SYSTEMS INC filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-046661), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including key positions affected, names of individuals, reasons for change, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material data points are provided in the available information.

11-02-2026

PulteGroup Inc./MI/ filed an 8-K on February 11, 2026 (AccNo: 0001104659-26-013404), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the provided filing summary. This is a multi-item voluntary disclosure with no quantitative metrics, transactions, or forward-looking information mentioned.

11-02-2026

Social Commerce Partners Corp filed an 8-K on February 11, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, comparisons, or directional impacts are mentioned.

11-02-2026

INTERNATIONAL FLAVORS & FRAGRANCES INC filed a Form 8-K on 2026-02-11 reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. This is a multi-item filing announcing financial results, but no specific revenue, earnings, margins, period-over-period changes, or other quantitative metrics are disclosed in the provided filing summary. No positive or negative performance indicators, guidance, or scheduled events were mentioned.

11-02-2026

Apple iSports Group, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001477932-26-000755), reporting under Item 1.02 the termination of a material definitive agreement. No details on the agreement's nature, parties, dollar value, strategic role, or financial implications were disclosed. This is a single-item mandatory disclosure with no other metrics or comparisons provided.

11-02-2026

Jefferies Financial Group Inc. filed an 8-K on February 11, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits (file size 255 KB, AccNo: 0001140361-26-004802). No specific details, financial metrics, transactions, positive or negative changes, or quantitative data are disclosed in the filing summary. This appears to be a voluntary disclosure of material information with attached exhibits.

11-02-2026

Bravo Multinational Inc. filed an 8-K on February 11, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals, reasons for change, or compensation are disclosed.

11-02-2026

Albemarle Corp filed an 8-K on February 11, 2026 (AccNo: 0000915913-26-000016), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or other financial metrics are disclosed in the provided filing information. No positive or negative performance changes, period-over-period comparisons, or operational details are mentioned.

11-02-2026

Service Corp International filed an 8-K on February 11, 2026 (AccNo: 0001628280-26-007289), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative details available for analysis.

11-02-2026

Comstock Resources Inc filed an 8-K on February 11, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, or period-over-period comparisons were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

11-02-2026

Crane NXT, Co. filed a Form 8-K on February 11, 2026 (AccNo: 0000025445-26-000005, Size: 853 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard voluntary earnings-related disclosure with attached exhibits.

• ·Multi-item 8-K filing (Items 2.02 and 9.01)
• ·Event Type: Financial Results
• ·Sector: NOT_DISCLOSED

11-02-2026

Jackson Financial Inc. filed an 8-K on February 11, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Specific details of the other events or contents of the exhibits are NOT_DISCLOSED. No financial metrics, transactions, or directional impacts are explicitly stated.

11-02-2026

CID Holdco, Inc. filed a Form 8-K on February 11, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, and under Item 3.01 notice of delisting or failure to satisfy a continued listing rule or standard, with Item 9.01 providing financial statements and exhibits. No quantitative details such as transaction values, financial impacts, dollar amounts, or specific terms are disclosed. This multi-item filing suggests potential financial distress without offsetting positive metrics disclosed.

11-02-2026

QuantumScape Corp filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-046623), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results, but specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are NOT_DISCLOSED. No positive or negative metrics, transaction values, or operational changes are detailed in the provided information.

11-02-2026

Essential Properties Realty Trust, Inc. filed an 8-K on February 11, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative metrics are disclosed in the provided information. This is a multi-item voluntary earnings-related disclosure.

11-02-2026

Piedmont Realty Trust, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001042776-26-000009), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, transaction details, guidance, or other quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

11-02-2026

Q2 Holdings, Inc. filed a Form 8-K on February 11, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This constitutes a voluntary disclosure of financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

11-02-2026

Morgan Stanley filed a Form 8-K on February 11, 2026, under Item 8.01 (Other Events), indicating disclosure of a material event not covered by other specific 8-K items. No details on the core event, financial impacts, transactions, or quantitative metrics are provided in the filing summary. This appears to be a single-item voluntary disclosure with file size of 322 KB and AccNo 0000950103-26-001967.

• ·File size: 322 KB
• ·AccNo: 0000950103-26-001967
• ·Event Type: General Filing
• ·Sector: NOT_DISCLOSED

11-02-2026

Aurora Innovation, Inc. filed an 8-K on February 11, 2026, reporting Results of Operations and Financial Condition under Item 2.02 and providing Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This appears to be a standard multi-item earnings-related disclosure.

11-02-2026

Angel Oak Mortgage REIT, Inc. filed an 8-K on February 11, 2026, specifically under Item 7.01 Regulation FD Disclosure. This is a voluntary disclosure to comply with Regulation FD, but the core content, financial metrics, transactions, or any quantitative data are NOT_DISCLOSED in the provided filing information. No positive, negative, or flat performance metrics are mentioned.

11-02-2026

FB Financial Corp filed an 8-K on February 11, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item voluntary filing with a file size of 9 MB, likely attaching disclosure materials such as a press release or presentation. No specific financial metrics, transactions, events, or quantitative data are disclosed in the provided filing summary.

11-02-2026

CNO Financial Group, Inc. filed an 8-K on 2026-02-11 disclosing matters under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. The filing also includes Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on affected positions, names, appointment or resignation status, reasons, or any quantitative metrics are disclosed.

• ·Sector: sector not specified
• ·Filing Accession Number: 0001224608-26-000011
• ·Filing Size: 484 KB

11-02-2026

National Bank Holdings Corp filed a Form 8-K on February 11, 2026, reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, along with Regulation FD disclosure in Item 7.01 and exhibits in Item 9.01. No quantitative details such as transaction values, financial terms, or impacts on revenue, earnings, balance sheet, or guidance are disclosed. This multi-item filing signals significant contractual and financing activity but provides no metrics for positive or negative assessment.

11-02-2026

Redwood Trust Inc filed an 8-K on February 11, 2026, reporting under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing related to financial results with no specific metrics, numbers, or performance details disclosed in the provided filing information. No positive or negative financial changes, guidance, or comparisons are mentioned.

11-02-2026

First American Financial Corp filed an 8-K on February 11, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or other quantitative financial metrics were mentioned in the filing details provided. This is a standard voluntary earnings release filing with no directional performance indicators available.

11-02-2026

ECA Marcellus Trust I filed a Form 8-K on February 11, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, or performance details (positive, negative, or flat) are disclosed in the provided filing information.

11-02-2026

Abpro Holdings, Inc. filed a Form 8-K on 2026-02-11 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing, which is a material negative event signaling potential loss of exchange trading status. The filing is multi-item, also disclosing under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No quantitative financial metrics, transaction values, or other numerical data are disclosed.

11-02-2026

Balance Labs, Inc. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included, but specific details on the affected position, appointment or resignation, reasons, or individuals involved are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or additional corporate actions were mentioned.

11-02-2026

Actelis Networks Inc filed a Form 8-K on February 11, 2026 (AccNo: 0001213900-26-014904), reporting solely under Item 8.01 Other Events. No details on the nature of the event, transaction values, financial metrics, or impacts are disclosed. This is a single-item voluntary filing with no quantitative data or scheduled events mentioned.

11-02-2026

PepsiCo Inc. filed an 8-K on February 11, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other event, financial statements, or exhibits are provided in the filing summary. No quantitative metrics, transactions, or impacts are disclosed.

11-02-2026

Interactive Strength, Inc. filed an 8-K on 2026-02-11 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and Item 3.02 (Unregistered Sales of Equity Securities). This multi-item filing indicates a likely financing-related transaction involving a new agreement, financial obligation, and equity issuance, but no quantitative details, terms, or impacts are disclosed. No positive or negative metrics, comparisons, or guidance changes are provided.

11-02-2026

Inception Growth Acquisition Ltd filed an 8-K on February 11, 2026, disclosing entry into a material definitive agreement under Item 1.01, amendments to articles of incorporation or bylaws and/or change in fiscal year under Item 5.03, submission of matters to a vote of security holders under Item 5.07, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative metrics, deal terms, parties involved, valuations, synergies, or performance comparisons are disclosed in the provided filing summary. This appears to be a SPAC-related merger announcement based on company name and items, but all specifics are NOT_DISCLOSED.

11-02-2026

Outset Medical, Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001193125-26-046588), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information.

11-02-2026

Palomar Holdings, Inc. filed a Form 8-K on February 11, 2026, under Item 2.02 to report results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed metrics available.

11-02-2026

Safehold Inc. filed a Form 8-K on February 11, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the provided filing information.

11-02-2026

Motorola Solutions, Inc. filed an 8-K on February 11, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure with no detailed performance data available.

11-02-2026

Teradata Corp filed an 8-K on February 11, 2026 (AccNo: 0001628280-26-007274), disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific transaction details, financial metrics, dollar values, or impacts are disclosed in the provided filing summary.

11-02-2026

Intuitive Machines, Inc. filed an 8-K on 2026-02-11 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are explicitly stated. No positive or negative metrics, financial impacts, or scheduled events were mentioned.

11-02-2026

HubSpot Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001193125-26-046563), reporting under Item 2.02 Results of Operations and Financial Condition, with Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or operational details are mentioned.

11-02-2026

INDEPENDENT BANK CORP filed an 8-K on February 11, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary provided. Critical details from the exhibits or disclosure content are missing.

11-02-2026

Local Bounti Corporation/DE filed a Form 8-K on 2026-02-11 under Items 3.01, 7.01, and 9.01, disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, along with Regulation FD disclosure and financial statements/exhibits. This event signals non-compliance with exchange listing requirements, potentially leading to transfer to over-the-counter trading. No quantitative financial metrics, positive developments, or period-over-period comparisons were disclosed.

• ·AccNo: 0001628280-26-007269
• ·Filing size: 194 KB
• ·Multi-item 8-K filing (Items 3.01, 7.01, 9.01)

11-02-2026

Paycom Software, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-046562), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item filing for financial results disclosure. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details.

11-02-2026

Waste Connections, Inc. filed a Form 8-K on February 11, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), disclosing financial results. This is a multi-item filing typical for earnings releases. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other numerical data are mentioned in the provided filing details.

11-02-2026

Phoenix Motor Inc. filed an 8-K on February 11, 2026 (AccNo: 0001493152-26-006203), reporting under Item 3.03 for material modifications to rights of security holders, Item 5.03 for amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 for financial statements and exhibits. This is a multi-item mandatory disclosure with no quantitative financial metrics, transaction values, or performance comparisons disclosed. Specific details on the nature, scope, or impact of the modifications or amendments are not provided.

11-02-2026

Bleichroeder Acquisition Corp. II filed an 8-K on 2026-02-11 (AccNo: 0001213900-26-014891) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No quantitative metrics, financial data, personnel names, dates, or merger/acquisition details are explicitly stated in the filing summary provided. Sector is not specified, and no positive or negative performance indicators are mentioned.

11-02-2026

Mativ Holdings, Inc. filed an 8-K on 2026-02-11 disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details such as names, positions affected, reasons for change, or quantitative data are disclosed.

11-02-2026

LightPath Technologies Inc. filed an 8-K on February 11, 2026, under Item 2.02 reporting Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a standard voluntary disclosure of financial results with no specific revenue, earnings, or other quantitative metrics detailed in the provided filing information. No period-over-period comparisons, guidance, or other financial impacts are disclosed.

11-02-2026

Porch Group, Inc. filed an 8-K on February 11, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but specific revenue, earnings, guidance, or other metrics are NOT_DISCLOSED. No positive or negative financial changes, period-over-period comparisons, or operational details are provided in the filing information.

11-02-2026

M&T Bank Corp filed an 8-K on February 11, 2026 (AccNo: 0000036270-26-000007, size 3 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure, likely attaching materials such as a press release or presentation, but specific content, financial metrics, transactions, or events are NOT_DISCLOSED. No positive or negative metrics are provided.

11-02-2026

Rollins Inc filed an 8-K on February 11, 2026, disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other financial metrics were mentioned in the provided filing details. The filing size was 790 KB with AccNo 0000084839-26-000003.

• ·AccNo: 0000084839-26-000003

11-02-2026

STAG Industrial, Inc. filed an 8-K on 2026-02-11 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet effects, guidance, period-over-period comparisons, or other quantitative metrics are mentioned in the filing summary. All financial details are NOT_DISCLOSED.

11-02-2026

Gladstone Investment Corporation filed an 8-K on February 11, 2026, reporting under Item 1.01 its entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details regarding the agreement's parties, terms, value, financial impacts, or any quantitative metrics are provided.

11-02-2026

AppLovin Corp filed an 8-K on February 11, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings release filing with attached financial statements.

11-02-2026

QuidelOrtho Corp filed an 8-K on February 11, 2026 (AccNo: 0001906324-26-000003), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative details are disclosed in the filing summary. This appears to be a standard earnings-related disclosure with exhibits likely including press releases or financial tables.

11-02-2026

Cisco Systems, Inc. filed a Form 8-K on February 11, 2026, under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or operational details are mentioned.

11-02-2026

Moog Inc. filed a Form 8-K on February 11, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, indicating results from a shareholder meeting were disclosed. This is a single-item filing with no specific details on proposals, vote outcomes, or any quantitative metrics provided in the excerpt. No financial impacts, guidance changes, or other material events are mentioned.

11-02-2026

Confluent, Inc. filed a Form 8-K on 2026-02-11 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative data are disclosed in the filing summary. This is a standard earnings-related disclosure without detailed performance indicators.

11-02-2026

Fastly, Inc. filed a Form 8-K on February 11, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

11-02-2026

Vanda Pharmaceuticals Inc. filed a Form 8-K on February 11, 2026, under Item 2.02 disclosing results of operations and financial condition and Item 9.01 providing financial statements and exhibits. This is a standard earnings-related disclosure typical for quarterly financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing summary.

11-02-2026

AEye, Inc. filed an 8-K on February 11, 2026, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.

11-02-2026

Penguin Solutions, Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001616533-26-000013), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the shareholder meeting date, proposals voted on, voting results, or outcomes (e.g., directors elected, proposals approved/rejected) are disclosed in the provided filing summary. This is a standard informational disclosure with no financial metrics, transaction details, or directional implications provided.

11-02-2026

Viking Therapeutics, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-046536), reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a standard voluntary disclosure for financial results, but no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided information. No positive or negative metrics are available for balanced assessment.

11-02-2026

Southern California Edison Co filed an 8-K on 2026-02-11 under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, terms, or financial impacts are disclosed.

11-02-2026

11-02-2026

CoreCivic, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-046527), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.

11-02-2026

Halliburton Co filed an 8-K on 2026-02-11 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions affected, reasons for change, effective dates, or quantitative details are disclosed in the provided filing summary. This appears to be a standard governance disclosure with no additional financial or operational metrics mentioned.

11-02-2026

Millerknoll, Inc. filed an 8-K on February 11, 2026 (AccNo: 0000066382-26-000031), disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed.

11-02-2026

Gouverneur Bancorp, Inc./MD/ filed an 8-K on February 11, 2026, disclosing Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters voted upon, vote results, attendance, or outcomes are provided in the filing summary. This is purely informational with no financial metrics, changes, or directional implications disclosed.

11-02-2026

Atomera Inc filed a Form 8-K on February 11, 2026, disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, accompanied by Item 9.01 for financial statements and exhibits. No specific details regarding the nature of the amendments, changes, or exhibits are provided. This is a multi-item informational filing with no quantitative financial impacts or directional metrics disclosed.

11-02-2026

PTC Inc. filed an 8-K on February 11, 2026, under Item 5.07, disclosing the submission of matters to a vote of security holders. This is a standard reporting of shareholder meeting vote results. No specific proposals, vote tallies, outcomes, or numerical data are disclosed in the provided filing information.

11-02-2026

McGraw Hill, Inc. filed an 8-K on February 11, 2026, under Item 2.02 disclosing results of operations and financial condition, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are mentioned in the provided filing details. This is an informational filing on financial results with all performance data NOT_DISCLOSED.

11-02-2026

Independence Realty Trust, Inc. filed a multi-item Form 8-K on February 11, 2026, reporting entry into a material definitive agreement (Item 1.01) and termination of a material definitive agreement (Item 1.02), alongside results of operations and financial condition (Item 2.02) and creation of a direct financial obligation (Item 2.03). Regulation FD disclosure (Item 7.01) was also included with financial statements and exhibits (Item 9.01). No specific transaction details, financial metrics, dollar values, or performance comparisons are disclosed.

11-02-2026

AMC Networks Inc. filed a Form 8-K on February 11, 2026 (AccNo: 0001514991-26-000008), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but specific revenue, earnings, comparisons, guidance, or other metrics are NOT_DISCLOSED in the provided details. No positive or negative performance indicators, period-over-period changes, or balance sheet effects are mentioned.

11-02-2026

Dakota Gold Corp. filed a Form 8-K on February 11, 2026 (AccNo: 0001104659-26-013353, Size: 564 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantitative metrics, transactions, or directional impacts mentioned.

11-02-2026

McDonald's Corp filed an 8-K on February 11, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance details, period-over-period comparisons, or strategic updates are mentioned.

11-02-2026

Tamboran Resources Corp filed an 8-K on February 11, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing details. This is an informational disclosure of financial results with attached exhibits, but key metrics remain NOT_DISCLOSED.

11-02-2026

Envoy Medical, Inc. filed an 8-K on 2026-02-11 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 listing Financial Statements and Exhibits. No specific details on the key position affected, appointment or resignation status, reasons, or timing are disclosed. No quantitative metrics, performance comparisons, or other financial data are mentioned.

11-02-2026

Amerant Bancorp Inc. filed an 8-K on February 11, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core event, financial metrics, transactions, or directional impacts are detailed in the provided filing information. All quantitative data, guidance, and operational details are NOT_DISCLOSED.

11-02-2026

SOUTH DAKOTA SOYBEAN PROCESSORS LLC filed a Form 8-K on February 11, 2026, reporting solely under Item 8.01 Other Events. No specific details regarding the event, financial metrics, transactions, or impacts are disclosed in the provided filing information. This appears to be a single-item, voluntary disclosure.

11-02-2026

World Acceptance Corp filed an 8-K on February 11, 2026, under Item 8.01 Other Events. No specific details regarding the nature of the event, financial metrics, transactions, or impacts were disclosed in the filing metadata provided. No quantitative data, comparisons, or directional indicators are available.

11-02-2026

Star Gold Corp. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, individuals involved, reasons for the change, or any financial metrics are provided in the filing summary. Sector is not specified.

11-02-2026

Neurocrine Biosciences Inc filed an 8-K on February 11, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

11-02-2026

Kinetic Seas Inc. filed a Form 8-K on February 11, 2026, reporting unregistered sales of equity securities under Item 3.02 and other events under Item 8.01. No quantitative details such as transaction value, share count, pricing, or financial impacts were disclosed. This multi-item filing provides limited information on the events, with no positive or negative metrics specified.

11-02-2026

Virtuix Holdings Inc. filed a Form 8-K on February 11, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of any exhibits are disclosed. No financial metrics, transactions, or performance data are mentioned.

11-02-2026

Microchip Technology Inc filed a Form 8-K on February 11, 2026 (AccNo: 0001193125-26-046713), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, impacts, or quantitative metrics disclosed in the provided information.

11-02-2026

Alaska Silver Corp. filed a Form 8-K on February 11, 2026 (AccNo: 0001062993-26-000786), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material non-public information to comply with Regulation FD, with exhibits attached, but no specific details on events, metrics, or transactions are provided in the filing header. No quantitative data, positive or negative metrics, or performance comparisons are mentioned.

11-02-2026

TreeHouse Foods, Inc. filed an 8-K on February 11, 2026, disclosing entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), and completion of an acquisition or disposition of assets (Item 2.01). The filing also reports creation of a direct financial obligation (Item 2.03), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), and departures/elections of directors/officers or compensatory arrangements (Item 5.02), along with amendments to articles of incorporation (Item 5.03). No quantitative financial metrics, deal values, parties, or performance comparisons were disclosed.

12-02-2026

Avient Corp filed an 8-K on February 12, 2026 (AccNo: 0001122976-26-000035), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing disclosing financial results, but specific revenue, earnings, margins, or other metrics are NOT_DISCLOSED. No period-over-period comparisons, guidance, or balance sheet details are provided in the filing summary.

12-02-2026

Quince Therapeutics, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-047544), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 8.01 (Other Events), indicating disclosure of financial results and additional events. No specific financial metrics, period-over-period comparisons, guidance, or transaction details are disclosed in the provided filing information. This is a multi-item filing focused on financial results.

12-02-2026

Lincoln National Corp filed an 8-K on February 12, 2026 (AccNo: 0000059558-26-000007, Size: 9 MB), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This multi-item filing pertains to financial results with no specific revenue, earnings, margins, or period-over-period comparisons detailed in the provided information. No positive or negative metrics, guidance, or scheduled events were explicitly stated.

12-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001062993-26-000822, Size: 587 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the core event, transaction values, financial metrics, or performance comparisons disclosed in the provided information. No quantitative data, period-over-period changes, positive or negative metrics, or strategic implications are available.

12-02-2026

Southwest Gas Holdings, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-047540), reporting under Item 1.02 the termination of a material definitive agreement. No financial terms, parties involved, strategic rationale, or impacts are disclosed.

12-02-2026

NovaBay Pharmaceuticals, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial impacts, transactions, or exhibits are disclosed in the provided filing information. The filing appears informational without quantified metrics or directional implications.

12-02-2026

Applied Materials Inc./DE filed a Form 8-K on February 12, 2026 (AccNo: 0001628280-26-007444, Size: 208 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, disclosures, financial statements, or exhibits are provided. This is a multi-item filing with no quantitative metrics, positive or negative, disclosed.

12-02-2026

Bally's Corp filed an 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events or content of the exhibits are disclosed in the filing summary. No financial metrics, transactions, or directional impacts are mentioned.

12-02-2026

News Corp filed a Form 8-K on February 12, 2026 (AccNo: 0001564708-26-000033, size: 399 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the provided filing information. This appears to be a multi-item informational filing with no quantitative metrics, positive or negative performance indicators, or directional implications provided.

12-02-2026

GEO Group Inc filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-047556), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other metrics are NOT_DISCLOSED. No positive or negative performance details, period-over-period comparisons, or balance sheet impacts are provided in the filing summary.

12-02-2026

US Foods Holding Corp. filed a Form 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information.

12-02-2026

SRx Health Solutions, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001493152-26-006259, Size: 220 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific details on the disclosed information, financial metrics, transactions, or performance provided in the filing summary. No quantitative data, period-over-period comparisons, or material events are explicitly stated.

12-02-2026

Materion Corp filed a Form 8-K on February 12, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are provided in the filing description. No positive or negative performance details, period-over-period comparisons, or operational highlights are mentioned.

• ·AccNo: 0001104657-26-000006
• ·File size: 907 KB
• ·Event Type: Financial Results

12-02-2026

RXO, Inc. filed a Form 8-K on February 12, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific details on the disclosed information, transaction values, financial metrics, or events provided in the filing summary. No quantitative data, positive or negative metrics, or period-over-period comparisons are mentioned.

12-02-2026

Vontier Corp filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007456), reporting under Item 2.02 Results of Operations and Financial Condition, with exhibits under Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative data are disclosed in the provided filing information. This appears to be a standard mandatory disclosure for financial results.

12-02-2026

Oak Woods Acquisition Corp filed an 8-K on 2026-02-12 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. Item 9.01 includes financial statements and exhibits. No merger/acquisition details, quantitative metrics, positive or negative performance indicators, or period-over-period comparisons are explicitly stated in the filing summary.

12-02-2026

Agios Pharmaceuticals, Inc. filed an 8-K on February 12, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative financial metrics were detailed in the provided filing information. This appears to be a standard earnings-related disclosure without extracted numerical impacts.

• ·Filing Accession Number: 0001439222-26-000023
• ·Filing size: 371 KB

12-02-2026

FTAI Aviation Ltd. filed an 8-K on 2026-02-12 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions, reasons for changes, timing, or quantitative details such as compensation amounts were provided. No positive or negative metrics, performance context, or governance implications were mentioned.

12-02-2026

Granite Construction Inc filed a Form 8-K on February 12, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons were disclosed in the provided filing details. This is a standard disclosure for financial results with no quantitative metrics available for analysis.

12-02-2026

Restaurant Brands International Inc. filed an 8-K on 2026-02-12 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative details available.

12-02-2026

Hyatt Hotels Corp filed an 8-K on 2026-02-12 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing metadata. This is a multi-item voluntary earnings-related disclosure.

12-02-2026

AquaBounty Technologies Inc. filed an 8-K on February 12, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial metrics, positive or negative impacts, or quantitative data are disclosed. This is a multi-item mandatory filing with no period-over-period comparisons or guidance provided.

12-02-2026

CarMax Inc filed an 8-K on February 12, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

BioXcel Therapeutics, Inc. filed a Form 8-K on February 12, 2026, under Item 8.01 Other Events. No specific details regarding the nature of the other event, financial impacts, or quantitative metrics are disclosed in the provided filing information. This appears to be a single-item voluntary disclosure.

12-02-2026

TripAdvisor, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001193125-26-047622), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or quantitative metrics were explicitly stated in the filing metadata provided. Sector information is not specified.

12-02-2026

Arvinas, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007463), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. This represents a standard disclosure requirement without additional context on positive or negative implications.

12-02-2026

CBRE Group, Inc. filed an 8-K on February 12, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing details. No guidance, balance sheet impacts, or other quantitative metrics are mentioned.

12-02-2026

Diebold Nixdorf, Inc filed an 8-K on February 12, 2026, under Item 2.02 to disclose results of operations and financial condition. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are provided in the filing excerpt. Sector details are not specified.

12-02-2026

TriNet Group, Inc. filed an 8-K on February 12, 2026 (AccNo: 0000937098-26-000006), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are disclosed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure with no mentioned positive or negative performance indicators.

12-02-2026

Commerce.com, Inc. filed an 8-K on February 12, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is an informational earnings-related filing with no quantitative details available.

12-02-2026

Crocs, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other numerical data are explicitly stated in the provided filing information.

12-02-2026

Howmet Aerospace Inc. filed an 8-K on February 12, 2026 (AccNo: 0001104659-26-013832), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, margins, guidance, or period-over-period comparisons are NOT_DISCLOSED. No quantitative metrics, strategic details, or performance directions (positive, negative, or flat) were explicitly stated.

12-02-2026

AMERICAN ELECTRIC POWER CO INC filed an 8-K on 2026-02-12 under Item 2.02 reporting Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing announcing financial results with no specific revenue, earnings, or other quantitative metrics disclosed in the provided information. No positive or negative performance indicators, comparisons, or guidance changes are detailed.

12-02-2026

DANA Inc filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, and any governance implications are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned in the provided filing information.

12-02-2026

Core Natural Resources, Inc. filed an 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or quantitative data including revenue, earnings, or balance sheet impacts are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached financial statements.

12-02-2026

ConnectOne Bancorp, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001437749-26-003852, size: 4 MB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or the content of any financial statements/exhibits are disclosed. This appears to be a multi-item voluntary disclosure with attached materials.

12-02-2026

Bruker Corp filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-047618), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons were disclosed in the provided filing details. This appears to be a standard voluntary disclosure of financial results with attached exhibits.

12-02-2026

P10, Inc. filed a Form 8-K on 2026-02-12 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement likely including earnings release and related materials. This is a multi-item filing typical for quarterly financial disclosures. No specific quantitative metrics, period-over-period changes, guidance, or other detailed financial data are disclosed in the provided filing information.

12-02-2026

Iridium Communications Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001418819-26-000008), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This constitutes a multi-item filing disclosing financial results with attached exhibits. No specific revenue, earnings, margins, or period-over-period metrics are detailed in the provided filing information.

12-02-2026

Sylvamo Corp filed an 8-K on February 12, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, or other quantitative metrics were disclosed in the provided filing details. This constitutes a standard earnings-related disclosure with no detailed performance data available.

12-02-2026

FirstEnergy Corp filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, timing, or any quantitative data are disclosed. No positive or negative metrics are mentioned.

12-02-2026

ADVANCED DRAINAGE SYSTEMS, INC. filed an 8-K on February 12, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, or operational details are disclosed in the filing summary. The disclosure appears informational with no mentioned positive or negative impacts.

12-02-2026

PHINIA INC. filed an 8-K on February 12, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

12-02-2026

Kelly Services Inc filed an 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed financial data available.

12-02-2026

Gates Industrial Corp plc filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007483), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet details, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings announcement filing.

• ·Filing Accession Number: 0001628280-26-007483
• ·Sector: not specified

12-02-2026

Alkermes plc filed an 8-K on February 12, 2026, disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), but also termination of a prior material definitive agreement (Item 1.02) and creation of a direct financial obligation (Item 2.03). Regulation FD disclosure was provided (Item 7.01) with financial statements and exhibits (Item 9.01). No specific transaction details, parties, values, or metrics are disclosed.

12-02-2026

Axos Financial, Inc. filed a Form 8-K on 2026-02-12 under Item 1.01 disclosing entry into a Material Definitive Agreement. Item 9.01 provides Financial Statements and Exhibits. No further details on the agreement, transaction size, financial impacts, or other metrics are disclosed.

12-02-2026

Soluna Holdings, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves voluntary disclosure of material non-public information with attached exhibits, but no specific transaction details, financial metrics, or operational data are mentioned. Critical content of the disclosure is missing from the provided summary.

12-02-2026

EDAP TMS SA filed an 8-K on 2026-02-12 disclosing an officer change or related matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, whether it was an appointment or resignation, reasons for the change, or any quantitative financial impacts are disclosed. Item 7.01 suggests potential material non-public information was shared, but content is NOT_DISCLOSED.

12-02-2026

Entergy Texas, Inc. filed an 8-K on February 12, 2026, reporting results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard multi-item earnings-related disclosure without detailed performance data.

• ·Multi-item 8-K filing (Items 2.02, 7.01, 9.01)

12-02-2026

Ryan Specialty Holdings, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 5.08 regarding Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 and Item 8.01 Other Events. No financial metrics, transaction details, quantitative data, or specific events were disclosed in the filing summary provided. This is an informational disclosure with no apparent positive or negative financial impacts mentioned.

12-02-2026

Optimum Communications, Inc. filed an 8-K on February 12, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or balance sheet details are available.

12-02-2026

Organon & Co. filed a Form 8-K on February 12, 2026 (AccNo: 0001104659-26-013888), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing typical for earnings releases, but specific revenue, earnings, guidance, or period-over-period metrics are NOT_DISCLOSED. No positive or negative financial changes, flat performance, or comparisons can be assessed due to lack of detailed data.

• ·Filing Accession Number: 0001104659-26-013888
• ·File Size: 6 MB
• ·Critical missing information: All financial metrics (revenue, EPS, margins), period-over-period changes (YoY/QoQ), guidance, scheduled events (earnings calls), named entities, insider activity, and specific results details affect analysis quality

12-02-2026

Avadel Pharmaceuticals PLC filed an 8-K on 2026-02-12 disclosing the completion of an acquisition or disposition of assets under Item 2.01, changes in control of the registrant under Item 5.01, and notice of delisting or failure to satisfy listing standards under Item 3.01. The filing also reports termination of a material definitive agreement (Item 1.02), material modifications to rights of security holders (Item 3.03), departures or elections of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), along with Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No quantitative financial metrics, deal values, parties, or specific terms were disclosed.

12-02-2026

LiveRamp Holdings, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0000733269-26-000017, Size: 164 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific events, transactions, financial metrics, or quantitative data are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure, but details of the core events or exhibits are NOT_DISCLOSED.

12-02-2026

Grace Therapeutics, Inc. filed an 8-K on February 12, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are detailed in the filing summary provided. This appears to be a standard earnings-related disclosure with exhibits likely containing press release or tables.

12-02-2026

Solidion Technology Inc. filed an 8-K on February 12, 2026, under Item 2.02 disclosing results of operations and financial condition. No specific financial metrics, revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were mentioned in the provided filing information. No positive or negative performance indicators were disclosed.

12-02-2026

Bloomin' Brands, Inc. filed an 8-K on February 12, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names, reasons, or timing are NOT_DISCLOSED.

12-02-2026

Theriva Biologics, Inc. filed an 8-K on February 12, 2026, under Item 8.01 Other Events. No specific details regarding the core event, financial impacts, transaction values, or metrics are disclosed in the filing summary. No positive or negative metrics are mentioned.

12-02-2026

Belden Inc. filed an 8-K on February 12, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the filing summary provided. This appears to be a standard earnings-related disclosure with no detailed performance data available.

12-02-2026

Alnylam Pharmaceuticals, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007491), disclosing results of operations and financial condition under Item 2.02 and providing financial statements and exhibits under Item 9.01. This is a multi-item filing focused on financial results announcement. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.

12-02-2026

Conduent Inc filed an 8-K on February 12, 2026, disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet changes, or other quantitative financial metrics are explicitly stated or extractable from the provided filing description. This multi-item filing represents a standard voluntary earnings-related disclosure with no detailed performance data available.

12-02-2026

IPG Photonics Corp filed an 8-K on 2026-02-12 reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. This is a multi-item filing typical for earnings releases. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details.

12-02-2026

Voyager Therapeutics, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, appointment or resignation, reasons, timing, or any quantitative data such as compensation amounts or share counts are disclosed. Sector is not specified.

12-02-2026

Evolv Technologies Holdings, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. Specific details regarding the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Cue Biopharma, Inc. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, effective dates, or any financial metrics are provided in the filing summary. This represents a standard governance disclosure with no quantified positive or negative impacts mentioned.

12-02-2026

Seagate Technology Holdings plc filed an 8-K on February 12, 2026, reporting multiple items including Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, financial metrics, or quantitative data disclosed in the provided information. No positive or negative performance metrics are mentioned.

12-02-2026

Aardvark Therapeutics, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, whether it is an appointment or resignation, reasons for the change, named individuals, effective dates, or any quantitative data such as compensation amounts are disclosed. No financial metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Euronet Worldwide, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, period-over-period changes, or other quantitative metrics were disclosed in the provided filing information. This appears to be a standard voluntary earnings release attachment.

12-02-2026

Onconetix, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001213900-26-015212, Size: 1 MB), reporting entry into a material definitive agreement under Item 1.01 and other events under Item 8.01. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, positive or negative impacts, or quantitative data are disclosed.

12-02-2026

12-02-2026

VerifyMe, Inc. filed a multi-item 8-K on February 12, 2026, disclosing entry into a new material definitive agreement (Item 1.01) while simultaneously terminating another material definitive agreement (Item 1.02), alongside changes involving departure or election of directors/officers and compensatory arrangements (Item 5.02), and Regulation FD disclosure (Item 7.01). No quantitative financial details, transaction values, or specific impacts are provided in the filing summary. Item 9.01 lists financial statements and exhibits, but contents are not detailed.

12-02-2026

Xerox Holdings Corp filed a Form 8-K on February 12, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial impacts, or quantitative metrics are provided in the available filing summary.

12-02-2026

Benitec Biopharma Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-047742), reporting under Item 2.02 Results of Operations and Financial Condition, with exhibits under Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or quantitative financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or transaction details are mentioned.

12-02-2026

Profound Medical Corp. filed a Form 8-K on February 12, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary filing focused on disseminating information previously provided selectively and attaching related exhibits. No specific financial metrics, transactions, or quantitative data are disclosed.

12-02-2026

Microbot Medical Inc. filed an 8-K on February 12, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely providing voluntary disclosure of material non-public information via attached exhibits. No specific events, financial metrics, transactions, or quantitative data are disclosed in the filing summary.

12-02-2026

Tectonic Financial, Inc. filed an 8-K on February 12, 2026, reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing also includes Regulation FD disclosure under Item 7.01 and lists financial statements and exhibits under Item 9.01. No quantitative details, dollar values, strategic impacts, or performance metrics are disclosed.

12-02-2026

Signing Day Sports, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001213900-26-015233, size: 238 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on voluntary disclosure of potentially material information and attached exhibits. No financial metrics, transactions, or specific events are detailed in the provided filing information.

12-02-2026

FIRST NATIONAL CORP /VA/ filed an 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed. No quantitative metrics, transactions, or financial impacts are mentioned.

12-02-2026

Ballston Spa Bancorp, Inc. filed an 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the provided filing information.

12-02-2026

60 Degrees Pharmaceuticals, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001213900-26-015239, Size: 238 KB), reporting solely under Item 8.01 Other Events. No details on the nature of the other event, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. Sector not specified.

12-02-2026

Sprout Social, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001517375-26-000003), disclosing results of operations and financial condition under Item 2.02 alongside an officer change or related event under Item 5.02. Item 5.02 covers potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, but specific details including names, positions, reasons, and timing are NOT_DISCLOSED. No financial metrics, quantitative changes, or performance comparisons are provided in the available information.

12-02-2026

Sonoco Products Co filed an 8-K on February 12, 2026 (AccNo: 0001104659-26-013958, Size: 226 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officers, positions, reasons for change, appointments, resignations, or any quantitative financial metrics are disclosed. The event is informational with no mentioned positive or negative performance indicators.

12-02-2026

Knight-Swift Transportation Holdings Inc. filed a Form 8-K on February 12, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the other events, transaction values, financial metrics, or exhibits disclosed in the provided filing summary. No positive, negative, or flat performance metrics are mentioned.

12-02-2026

Trinity Industries Inc filed an 8-K on February 12, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), disclosing financial results. This is a multi-item filing typical for earnings releases. No specific revenue, earnings, guidance, or quantitative metrics were detailed in the provided filing information.

12-02-2026

Tron Inc. filed a Form 8-K on February 12, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the disclosed information, transaction values, financial metrics, or exhibits provided in the summary. No quantitative data, period-over-period comparisons, or material events are explicitly stated.

12-02-2026

Enhabit, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing furnishes material non-public information under Regulation FD safe harbor and attaches relevant exhibits. No quantitative financial metrics, transaction details, period-over-period comparisons, or scheduled events are disclosed in the filing metadata.

12-02-2026

Under Armour, Inc. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer, position affected, reason for change, or any quantitative metrics are disclosed.

12-02-2026

Totaligent, Inc. filed an 8-K on February 12, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement's terms, parties, value, strategic importance, or financial impact were disclosed. This is a multi-item mandatory filing with no quantitative metrics or period-over-period comparisons provided.

12-02-2026

Annovis Bio, Inc. filed a Form 8-K on February 12, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing indicating voluntary public release of material information to comply with Regulation FD, with exhibits likely attached such as a press release. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary.

12-02-2026

Lincoln Electric Holdings Inc filed an 8-K on February 12, 2026 (AccNo: 0000059527-26-000003, Size: 1 MB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were disclosed in the provided filing information. This is a standard earnings-related disclosure without quantified metrics.

• ·Event Type: Financial Results
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

12-02-2026

CSP Inc. (/MA/) filed an 8-K on February 12, 2026, reporting under Item 2.02 its results of operations and financial condition, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative details were disclosed in the provided filing information. This represents a standard voluntary disclosure of financial results without directional indicators.

12-02-2026

ADDENTAX GROUP CORP. filed a Form 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the exhibits are disclosed in the filing summary. File size is 229 KB with Accession Number 0001493152-26-006327.

12-02-2026

Contango ORE, Inc. filed an 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction size, financial impacts, or events are provided in the available information. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

12-02-2026

SAGA COMMUNICATIONS INC filed a Form 8-K on February 12, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events or the contents of the exhibits are provided. All quantitative data, transaction details, and financial impacts are NOT_DISCLOSED.

12-02-2026

Indaptus Therapeutics, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001493152-26-006330), reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are disclosed. This is a multi-item filing focused on material contractual and equity events without specified positive or negative metrics.

12-02-2026

INNOVATIVE SOLUTIONS & SUPPORT INC filed an 8-K on February 12, 2026, under Item 2.02 reporting Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative data are disclosed in the provided filing details. This appears to be a standard voluntary earnings announcement without detailed performance highlights.

12-02-2026

TEREX CORP filed an 8-K on February 12, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits provided under Item 9.01. No specific revenue, earnings, guidance, balance sheet details, period-over-period comparisons, or other quantitative financial metrics are mentioned in the filing summary. This appears to be a standard earnings-related disclosure without detailed performance data provided.

12-02-2026

Tootsie Roll Industries Inc filed an 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are provided in the filing summary. This is a standard earnings-related disclosure without quantified metrics.

12-02-2026

Aspire Biopharma Holdings, Inc. filed a multi-item Form 8-K on February 12, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departures or appointments of directors/officers or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details, transaction values, financial impacts, or quantitative metrics are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

12-02-2026

NorthWestern Energy Group, Inc. filed an 8-K on February 12, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, period-over-period comparisons, or other quantitative data are provided in the filing information.

12-02-2026

BION ENVIRONMENTAL TECHNOLOGIES INC filed an 8-K on February 12, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the disclosed information, transaction values, financial metrics, or exhibits provided. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

12-02-2026

Magyar Bancorp, Inc. filed an 8-K on February 12, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, likely related to a shareholder meeting, and under Item 9.01 financial statements and exhibits. No specific vote outcomes, financial metrics, positive or negative changes, or other quantitative details are disclosed.

12-02-2026

Fresh Del Monte Produce Inc filed an 8-K on 2026-02-12 disclosing entry into a material definitive agreement under Item 1.01. The filing also includes financial statements and exhibits under Item 9.01. No details on the agreement terms, parties, financial impact, or quantitative metrics are provided.

12-02-2026

FVCBankcorp, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001675644-26-000006, size: 25 MB), reporting multiple items including entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative metrics, transaction details, financial impacts, period-over-period comparisons, or specific terms are disclosed.

• ·Multi-item 8-K filing (5 items reported)
• ·File size: 25 MB (suggests detailed exhibits)

12-02-2026

Direct Digital Holdings, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). The core event or details of the 'Other Events' and contents of the exhibits are NOT_DISCLOSED. No financial metrics, transactions, or directional impacts are specified in the filing summary.

12-02-2026

CIM Real Estate Finance Trust, Inc. filed an 8-K on February 12, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No transaction details, dollar values, financial metrics, or impacts are disclosed.

12-02-2026

Yum Brands Inc. filed an 8-K on February 12, 2026 (AccNo: 0001041061-26-000069), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, reasons for change, or any quantitative metrics such as compensation amounts are disclosed in the provided filing summary. No positive or negative performance metrics, comparisons, or financial impacts are mentioned.

12-02-2026

FIRST US BANCSHARES, INC. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, timing, or any quantitative metrics are disclosed.

12-02-2026

AMETEK Inc. filed a Form 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of any exhibits are disclosed in the provided filing summary. No quantitative metrics, transactions, or directional impacts are mentioned.

12-02-2026

Tennessee Valley Authority filed an 8-K on 2026-02-12 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed in the provided filing information. No positive or negative performance metrics are mentioned.

12-02-2026

VASO Corp filed an 8-K on February 12, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws, or a change in fiscal year. Item 9.01 discloses financial statements and exhibits. No specific details, financial metrics, positive or negative changes, or quantitative impacts are provided in the filing summary.

12-02-2026

TRANSUITE.ORG INC. filed a Form 8-K on 2026-02-12 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons for change, or any quantitative data are provided. No positive or negative metrics mentioned.

12-02-2026

CareTrust REIT, Inc. filed an 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period changes, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance variations.

12-02-2026

Pegasystems Inc filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected position, individual involved, reason for change, or any quantitative metrics are disclosed.

12-02-2026

Kentucky First Federal Bancorp filed a Form 8-K on February 12, 2026 (AccNo: 0001213900-26-015539), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This represents a standard voluntary earnings-related disclosure with no specific revenue, earnings, balance sheet changes, or period-over-period comparisons detailed in the provided filing information. No positive or negative financial metrics were quantified.

12-02-2026

Verses AI Inc. filed an 8-K on 2026-02-12 disclosing officer changes or appointments under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on affected positions, names, reasons for change, or any quantitative metrics are provided. No positive or negative performance metrics mentioned.

12-02-2026

Roku, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative results were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data.

12-02-2026

MIAMI INTERNATIONAL HOLDINGS, INC. filed an 8-K on February 12, 2026, reporting under Item 3.02 regarding unregistered sales of equity securities. No quantitative details such as transaction value, share count, recipients, or pricing were disclosed. This disclosure is informational without specified financial or strategic context.

12-02-2026

Sensus Healthcare, Inc. filed a Form 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This represents a standard earnings-related disclosure. No specific revenue, earnings, margins, period-over-period changes, guidance, or other financial metrics are mentioned in the provided filing details.

12-02-2026

SPS COMMERCE INC filed an 8-K on 2026-02-12 disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details regarding the officer change, including position affected, appointment or resignation status, reasons, timing, financial results, or any metrics are NOT_DISCLOSED. The filing size is 701 KB with AccNo 0001092699-26-000007.

12-02-2026

Arista Networks, Inc. filed an 8-K on February 12, 2026, under Item 2.02 announcing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without extracted numerical data.

12-02-2026

Seaboard Corp /DE/ filed a Form 8-K on February 12, 2026, reporting Results of Operations and Financial Condition under Item 2.02. Item 9.01 includes Financial Statements and Exhibits. No specific revenue, earnings, balance sheet metrics, period-over-period changes, or guidance are disclosed in the provided filing information.

• ·AccNo: 0000088121-26-000010
• ·File Size: 223 KB
• ·Sector: sector not specified

12-02-2026

Arteris, Inc. filed an 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating the announcement of financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing summary. No period-over-period comparisons, positive or negative changes, or financial impacts are mentioned.

12-02-2026

Flux Power Holdings, Inc. filed an 8-K on 2026-02-12 (AccNo: 0001493152-26-006404, size: 347 KB) disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item voluntary filing typical for earnings releases. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information.

12-02-2026

HA Sustainable Infrastructure Capital, Inc. filed an 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the filing summary. This is a standard voluntary disclosure for financial results transparency.

12-02-2026

Pinterest, Inc. filed a Form 8-K on February 12, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing typical for earnings releases. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

12-02-2026

Kenvue Inc. filed an 8-K on 2026-02-12 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons for change, or timing are provided in the filing summary. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

• ·Filing Accession Number: 0000950157-26-000133
• ·File Size: 155 KB
• ·Sector: NOT_DISCLOSED

12-02-2026

Phillips Edison & Company, Inc. filed an 8-K on February 12, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, events, or quantitative data are detailed in the filing summary provided. Critical details of the disclosure are missing, limiting assessment of impact.

12-02-2026

Fathom Holdings Inc. filed a Form 8-K on February 12, 2026, reporting Changes in Control of Registrant under Item 5.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This multi-item filing indicates a potentially material governance event but provides no specific details on the nature of the control change, transaction terms, or financial impacts. No quantitative metrics, positive or negative performance indicators, or period-over-period comparisons are disclosed.

12-02-2026

Olin Corp filed an 8-K on February 12, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or exhibits are provided in the filing summary. This appears to be a voluntary informational filing with no quantified impacts disclosed.

12-02-2026

Dutch Bros Inc. filed an 8-K on February 12, 2026 (AccNo: 0001866581-26-000003, Size: 869 KB), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing typical for earnings releases, but no specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided information. No positive or negative performance metrics, period-over-period comparisons, or operational details are available.

12-02-2026

Galera Therapeutics, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048696), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including the key position affected, names of individuals, nature of change (appointment or resignation), reasons, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.

12-02-2026

Quaint Oak Bancorp, Inc. filed an 8-K on February 12, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 discloses financial statements and exhibits. No specific details, financial metrics, dollar values, or impacts are provided.

12-02-2026

Repay Holdings Corp filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

12-02-2026

BridgeBio Pharma, Inc. filed an 8-K on February 12, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the nature of the other events or exhibits provided in the summary. No financial metrics, transactions, or performance data are disclosed.

12-02-2026

Jet.AI Inc. filed a multi-item 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01, which may have strategic implications, but also a notice of delisting or failure to satisfy a continued listing rule or standard under Item 3.01, signaling potential removal from exchange listing and liquidity risks. Item 8.01 reports other events and Item 9.01 includes financial statements and exhibits. No transaction values, financial impacts, or specific details on the agreement or delisting triggers are disclosed.

12-02-2026

Hennessy Capital Investment Corp. VIII filed a Form 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the nature of the other events or the content of the exhibits provided in the summary. No financial metrics, transactions, or impacts are disclosed.

12-02-2026

MASCO CORP /DE/ filed an 8-K on 2026-02-12 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for changes, or any quantitative metrics are provided in the filing summary. No positive or negative performance metrics, financial impacts, or further context are mentioned.

12-02-2026

Ryerson Holding Corp filed an 8-K on February 12, 2026, under Items 5.07 (Submission of Matters to a Vote of Security Holders), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). Specific details on vote results, the nature of other events, or contents of exhibits are NOT_DISCLOSED. No financial metrics, changes, or directional impacts are mentioned.

12-02-2026

Curbline Properties Corp. filed a Form 8-K on February 12, 2026 (AccNo: 0001193125-26-048693, Size: 832 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial impacts, or exhibits are disclosed in the provided filing summary. Critical event details and quantitative metrics are NOT_DISCLOSED.

12-02-2026

Citigroup Inc. filed an 8-K on February 12, 2026, under Item 5.03 reporting amendments to its Articles of Incorporation or Bylaws, or a change in fiscal year. Item 9.01 discloses financial statements and exhibits. No details on the nature of amendments, financial impacts, or quantitative metrics were provided.

12-02-2026

Sixth Street Specialty Lending, Inc. filed an 8-K on 2026-02-12 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing details. This is a multi-item voluntary earnings-related disclosure.

12-02-2026

Beam Therapeutics Inc. filed an 8-K on 2026-02-12 disclosing entry into a material definitive agreement under Item 1.01, accompanied by financial statements and exhibits under Item 9.01. No specific details on the agreement's terms, parties, value, or financial impacts are disclosed. No quantitative metrics, positive or negative changes, or performance comparisons are provided.

• ·AccNo: 0001193125-26-048684
• ·Filing size: 230 KB

12-02-2026

Forrester Research, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001193125-26-048685), reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure with attached exhibits containing further details.

12-02-2026

Warrior Met Coal, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001193125-26-048678, Size: 1 MB), reporting results of operations and financial condition under Item 2.02. The filing includes financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information.

• ·AccNo: 0001193125-26-048678
• ·Event Type: Financial Results
• ·Source: us_sec
• ·Sector: not specified

12-02-2026

Sabra Health Care REIT, Inc. filed an 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, guidance, or period-over-period metrics were detailed in the provided information. No positive or negative financial changes, transaction values, or operational metrics were mentioned.

12-02-2026

SOLIGENIX, INC. filed a Form 8-K on February 12, 2026 (AccNo: 0001104659-26-014267, Size: 226 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the financial statements/exhibits are disclosed. No quantitative metrics, positive or negative changes, or performance comparisons provided.

12-02-2026

Vertex Pharmaceuticals Inc. / MA filed a Form 8-K on February 12, 2026 (AccNo: 0000875320-26-000034), reporting results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. This is a multi-item filing typical for earnings releases, but no specific revenue, earnings, guidance, balance sheet details, or other quantitative metrics were explicitly stated. No positive, negative, or flat performance indicators were disclosed.

12-02-2026

Teladoc Health, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001477449-26-000002), disclosing an Item 5.02 event related to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or financial terms are disclosed. No quantitative metrics, performance comparisons, or other financial data are mentioned.

12-02-2026

Procore Technologies, Inc. filed an 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were disclosed in the filing summary. This is an informational earnings-related disclosure without quantified financial metrics.

12-02-2026

Dexcom Inc filed a Form 8-K on February 12, 2026 (AccNo: 0001093557-26-000025, Size: 692 KB), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This multi-item filing represents a standard voluntary earnings-related disclosure. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics were detailed in the provided filing information.

12-02-2026

Walt Disney Co filed a Form 8-K on February 12, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events or the contents of the exhibits are disclosed in the provided filing summary. This is a multi-item filing with no quantitative financial metrics, positive or negative developments, or performance comparisons mentioned.

12-02-2026

Airbnb, Inc. filed an 8-K on February 12, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. This appears to be an earnings release announcement. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

12-02-2026

Edgemode, Inc. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or any quantitative metrics are provided.

12-02-2026

Cohu Inc filed an 8-K on February 12, 2026 (AccNo: 0001437749-26-003937), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard disclosure for financial results, but no specific revenue, earnings, guidance, or other metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or balance sheet details are available.

• ·Multi-item 8-K filing focused on financial results disclosure.
• ·Sector NOT_DISCLOSED.
• ·No forward-looking statements, risk factors, or guidance extracted.

12-02-2026

Rivian Automotive, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a voluntary disclosure of financial results typically accompanying an earnings release. This is a multi-item filing with no specific revenue, earnings, balance sheet effects, guidance, or other quantitative metrics explicitly stated in the provided information. No positive, negative, or flat performance indicators are disclosed.

12-02-2026

Trupanion, Inc. filed an 8-K on February 12, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the provided filing information. No positive or negative financial changes are detailed.

12-02-2026

Arhaus, Inc. filed a Form 8-K on February 12, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific events, transactions, financial metrics, positive or negative changes, or quantitative data are disclosed in the filing summary provided. The disclosure appears informational without directional implications.

12-02-2026

Vishay Intertechnology Inc filed an 8-K on February 12, 2026 (AccNo: 0000103730-26-000015), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financial metrics, or exhibits are disclosed in the provided filing summary. This is a multi-item informational filing with no quantified positive or negative impacts mentioned.

12-02-2026

Pro-Dex Inc filed an 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01, completion of an acquisition or disposition of assets under Item 2.01, and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. Regulation FD disclosure was provided under Item 7.01, with financial statements and exhibits attached under Item 9.01. No specific transaction details, parties, values, or metrics are disclosed in the provided filing summary.

12-02-2026

12-02-2026

Bio-Rad Laboratories, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0000012208-26-000007), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, margins, guidance, or period-over-period comparisons in the available information. All quantitative metrics are NOT_DISCLOSED.

12-02-2026

Solaris Energy Infrastructure, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048667), reporting under Item 1.01 entry into a Material Definitive Agreement. No details on the core event, transaction value, parties involved, financial impact, or strategic importance are disclosed. No quantitative metrics, period-over-period comparisons, or other data points such as revenue, earnings, guidance, or balance sheet effects are provided.

12-02-2026

American Well Corp filed an 8-K on February 12, 2026, reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial details are disclosed in the provided filing information. This constitutes a standard voluntary earnings-related disclosure without directional performance indicators.

• ·Filing Accession Number: 0001193125-26-048737
• ·File Size: 714 KB
• ·ANALYSIS CONFIDENCE: LOW (<50%) - Critical missing information: all financial metrics (revenue, earnings, EPS, margins), period-over-period comparisons (YoY/QoQ), guidance/outlook, balance sheet details, cash/debt changes, scheduled events (earnings calls), named executives/products/initiatives, insider activity, forward-looking statements, and actual results content from Items 2.02/9.01

12-02-2026

Rambus Inc filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

12-02-2026

Public Storage filed an 8-K on February 12, 2026, under Item 5.02 disclosing departure of directors or certain officers, election or appointment of directors/officers, or compensatory arrangements; Item 7.01 for Regulation FD disclosure; Item 8.01 for other events; and Item 9.01 for financial statements and exhibits. No specific details on the officer affected, position, appointment/resignation status, reasons, or any financial metrics are disclosed. This filing provides limited transparency on the leadership change event.

12-02-2026

10x Genomics, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007673), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information.

12-02-2026

agilon health, inc. filed a Form 8-K on February 12, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, parties, terms, or financial impacts are disclosed in the provided filing summary.

• ·Accession Number: 0001628280-26-007671
• ·Multi-item 8-K filing (Items 1.01, 2.03, 9.01)
• ·Sector: NOT_DISCLOSED

12-02-2026

Maplebear Inc. filed an 8-K on February 12, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

12-02-2026

Thermo Fisher Scientific Inc. filed an 8-K on February 12, 2026 (AccNo: 0001140361-26-005014), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed in the provided filing summary.

12-02-2026

Healthcare Realty Trust Inc filed a Form 8-K on February 12, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. This is a multi-item filing typical for earnings releases. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

12-02-2026

Capstone Green Energy Holdings, Inc. filed an 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information.

12-02-2026

CVR Energy Inc. filed an 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with exhibits under Item 9.01. This multi-item filing signals a significant contractual commitment and new financial liability, but no details on terms, size, or impacts are provided. No quantitative metrics, positive or negative changes, or performance comparisons are disclosed.

12-02-2026

VenHub Global, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001213900-26-015576), reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction values, financial metrics, or performance comparisons disclosed. No positive or negative metrics are provided.

12-02-2026

Supernus Pharmaceuticals, Inc. filed an 8-K on February 12, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, and Item 9.01 providing Financial Statements and Exhibits. No specific revenue, earnings, or other quantitative financial metrics are disclosed in the filing description. This appears to be a standard earnings-related disclosure with attached exhibits, but detailed performance data is not available.

12-02-2026

Fortune Brands Innovations, Inc. filed an 8-K on February 12, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details including the key position affected, name of the officer, reason for change, appointment or resignation status, timing, and any financial metrics are NOT_DISCLOSED. No positive or negative metrics, scheduled events, or quantitative data are provided in the filing summary.

12-02-2026

Mercer International Inc. filed a Form 8-K on February 12, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), indicating a standard disclosure of earnings-related information. No specific revenue, earnings, balance sheet metrics, guidance, or period-over-period comparisons were explicitly stated in the provided filing details. This is a multi-item filing focused on financial results without quantified impacts disclosed.

12-02-2026

Catheter Precision, Inc. filed a multi-item 8-K on February 12, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD disclosure (Item 7.01). While the material agreement may signal strategic progress, the unregistered equity sales raise potential dilution concerns and the governance changes introduce uncertainty without specified details. No quantitative transaction values, share counts, financial impacts, or period-over-period comparisons are disclosed.

12-02-2026

Anebulo Pharmaceuticals, Inc. filed an 8-K on February 12, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, revenue, earnings, balance sheet details, or period-over-period comparisons were disclosed in the filing summary provided. This appears to be a standard earnings-related disclosure without quantified data.

12-02-2026

Flowers Foods Inc filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048756), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, balance sheet effects, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed performance data available.

12-02-2026

Bain Capital GSS Investment Corp. filed an 8-K on February 12, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed.

12-02-2026

Lunai Bioworks Inc. filed a Form 8-K on 2026-02-12 disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, which represents a material negative event signaling potential removal from U.S. exchange trading. Item 7.01 includes a Regulation FD Disclosure. No financial metrics, positive developments, or quantitative details are disclosed.

12-02-2026

Sphere 3D Corp. filed a Form 8-K on February 12, 2026, reporting under Item 3.03 material modifications to the rights of security holders and under Item 5.03 amendments to its articles of incorporation or bylaws or a change in fiscal year. The filing also includes Item 7.01 for Regulation FD disclosure and Item 9.01 for financial statements and exhibits. No quantitative financial metrics, transaction values, or specific details on the modifications, impacts, or exhibits were disclosed in the provided information.

12-02-2026

Aethlon Medical Inc filed an 8-K on February 12, 2026 (AccNo: 0001683168-26-000959), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are provided in the filing summary. All quantitative financial metrics are NOT_DISCLOSED.

12-02-2026

Haemonetics Corp filed an 8-K on February 12, 2026, reporting under Item 7.01 Regulation FD Disclosure. No specific details on the disclosed information, financial metrics, transactions, or events are provided in the filing summary. This is a voluntary disclosure with no quantitative data or period-over-period comparisons mentioned.

12-02-2026

AVITA Medical, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons were disclosed in the provided filing information. The filing size is 518 KB with Accession Number 0001193125-26-048761.

• ·Filing Accession Number: 0001193125-26-048761
• ·Filing size: 518 KB
• ·Event Type: Financial Results
• ·Sector: NOT_DISCLOSED

12-02-2026

FrontView REIT, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048763), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or quantitative metrics are disclosed in the provided information. No positive or negative performance metrics, period-over-period comparisons, or guidance changes are mentioned.

12-02-2026

loanDepot, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001831631-26-000004), disclosing entry into a Credit Agreement under Item 8.01 Other Events. No specific dollar values, terms, financial impacts, or other metrics were mentioned in the filing details provided. This represents a voluntary disclosure of a financing-related event.

12-02-2026

Presurance Holdings, Inc. filed a Form 8-K on February 12, 2026, under Item 8.01 disclosing Other Events. No specific details regarding the nature of the event, financial metrics, transactions, or impacts are provided in the filing summary. No positive, negative, or flat metrics are mentioned.

12-02-2026

Rezolute, Inc. filed a Form 8-K on 2026-02-12 under Item 2.02 announcing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics were disclosed in the provided filing description.

12-02-2026

Bright Horizons Family Solutions Inc. filed an 8-K on February 12, 2026, reporting results of operations and financial condition under Item 2.02 and officer departures, elections, appointments, or compensatory arrangements under Item 5.02. Financial statements and exhibits are provided under Item 9.01. No specific details on the officer change (e.g., position, reason, internal/external), financial metrics, or period-over-period comparisons are disclosed.

12-02-2026

Kinsale Capital Group, Inc. filed a Form 8-K on 2026-02-12 under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This is a standard earnings-related disclosure with no specific quantitative metrics, comparisons, or guidance detailed in the provided filing information. No positive or negative financial changes are explicitly stated.

12-02-2026

BioMarin Pharmaceutical Inc filed an 8-K on February 12, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing for material events, but specific details on the agreement, transaction size, parties, or financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

12-02-2026

Ultragenyx Pharmaceutical Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001193125-26-048738), reporting results of operations and financial condition under Item 2.02 alongside costs associated with exit or disposal activities under Item 2.05, with financial statements and exhibits under Item 9.01. This multi-item filing provides an update on financial performance but highlights potential negative impacts from exit-related costs. No specific revenue, earnings, cost amounts, or period-over-period comparisons are disclosed.

12-02-2026

Toast, Inc. filed an 8-K on February 12, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific metrics, comparisons, or details in the summary provided. No quantitative data, guidance, or scheduled events mentioned.

12-02-2026

NMI Holdings, Inc. filed an 8-K on February 12, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details regarding the key position affected, appointment or resignation, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

12-02-2026

Pacific Biosciences of California, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001299130-26-000017), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing information.

12-02-2026

Constellation Brands, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details regarding the key position affected, whether it is an appointment or resignation, reasons for the change, or any governance implications are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

CROSS COUNTRY HEALTHCARE INC filed an 8-K on February 12, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material information previously shared orally, with exhibits attached. No specific financial metrics, transactions, or operational details are disclosed in the provided filing summary.

12-02-2026

PDF Solutions Inc filed an 8-K on February 12, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics were disclosed in the provided filing details. This represents a standard earnings-related disclosure without detailed performance data.

12-02-2026

Mohawk Industries Inc filed an 8-K on February 12, 2026 (AccNo: 0000851968-26-000005, Size: 2 MB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing details. No positive, negative, or flat performance indicators were mentioned.

• ·Filing Accession Number: 0000851968-26-000005
• ·Filing Size: 2 MB

12-02-2026

Air Lease Corp filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007701), reporting under Item 2.02 Results of Operations and Financial Condition, with Item 9.01 attaching Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing summary. This is a standard earnings-related disclosure with no quantitative financial data available.

12-02-2026

Ameriprise Financial Inc filed an 8-K on February 12, 2026 (AccNo: 0001104659-26-014312), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or financial terms are provided. No quantitative metrics, performance comparisons, or other financial data are mentioned.

12-02-2026

NU Skin Enterprises, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001140361-26-005018), reporting results of operations and financial condition under Item 2.02. The filing also includes financial statements and exhibits under Item 9.01. No specific revenue, earnings, comparisons, or other quantitative metrics are explicitly stated in the provided filing details.

12-02-2026

Norwegian Cruise Line Holdings Ltd. filed an 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, an officer change or election/appointment under Item 5.02, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or financial metrics are provided in the filing summary. Sector not specified.

12-02-2026

Grand Canyon Education, Inc. filed an 8-K on 2026-02-12 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

CVRx, Inc. filed an 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the provided filing information. This is an informational earnings-related disclosure without detailed performance data.

12-02-2026

Brighthouse Financial, Inc. filed a Form 8-K on February 12, 2026, reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely related to annual shareholder meeting outcomes and additional material disclosures. No specific vote results, quantitative financial metrics, positive or negative changes, or other details are disclosed in the provided filing summary.

12-02-2026

Hercules Capital, Inc. filed an 8-K on February 12, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing information. Detailed results are presumably in the attached exhibits, but NOT_DISCLOSED here.

12-02-2026

MVB Financial Corp filed an 8-K on February 12, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative details are mentioned in the filing description. This is a standard earnings-related disclosure for a financial institution.

12-02-2026

Murphy USA Inc. filed an 8-K on February 12, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This multi-item filing is primarily voluntary, aimed at publicly disclosing material non-public information via attached exhibits. No quantitative metrics, transactions, period-over-period comparisons, financial impacts, or scheduled events are explicitly stated in the filing summary.

12-02-2026

Vistagen Therapeutics, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007715), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance are disclosed in the provided filing information. This is a standard multi-item disclosure for financial results.

12-02-2026

CRISPR Therapeutics AG filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048873), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard voluntary earnings release disclosure.

12-02-2026

Ashford Hospitality Trust Inc. filed an 8-K on February 12, 2026, announcing under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 provides financial statements and exhibits related to the transaction. No specific details on parties, deal value, terms, or financial impacts are disclosed.

12-02-2026

Morningstar, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001289419-26-000009, Size: 8 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results, but no specific revenue, earnings, margins, or period-over-period comparisons are explicitly stated. No positive or negative metrics are detailed in the provided filing information.

12-02-2026

Childrens Place, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed.

12-02-2026

ETHZilla Corp filed an 8-K on February 12, 2026, reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws or a change in Fiscal Year, under Item 7.01 Regulation FD Disclosure, and under Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with both mandatory (Item 5.03) and voluntary (Item 7.01) elements. No specific details, numerical values, transaction sizes, financial impacts, or other metrics are disclosed.

12-02-2026

PodcastOne, Inc. filed an 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.

• ·AccNo: 0001213900-26-015621
• ·File size: 346 KB
• ·Filing date: 2026-02-12

12-02-2026

Liberty Latin America Ltd. filed an 8-K on February 12, 2026 (AccNo: 0001712184-26-000014, Size: 220 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of potentially material information with attached exhibits. No quantitative financial metrics, transactions, period-over-period comparisons, or specific events detailed in the provided filing information.

12-02-2026

Digimarc CORP filed an 8-K on February 12, 2026 (AccNo: 0001437749-26-003950), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, nature of the change (appointment or resignation), reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

12-02-2026

Visa Inc. filed an 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, financial metrics, transactions, or impacts are disclosed in the provided filing information.

12-02-2026

12-02-2026

Great Lakes Dredge & Dock CORP filed a Form 8-K on February 12, 2026 (AccNo: 0001171843-26-000790), reporting solely under Item 8.01 Other Events. No details on the specific event, transaction, financial metrics, or impacts are disclosed in the provided filing information. This appears to be a single-item, likely voluntary disclosure of an unspecified material event.

12-02-2026

Ingersoll Rand Inc. filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007710), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, balance sheet impacts, or other quantitative financial metrics are disclosed in the provided filing information. No period-over-period comparisons, positive or negative changes, or operational details are available.

12-02-2026

Celcuity Inc. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also includes Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. Specific details including names, positions, reasons, or compensation are NOT_DISCLOSED.

12-02-2026

Farmers & Merchants Bancorp filed an 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Specific details of the other event, any financial statements, or exhibits are NOT_DISCLOSED in the provided filing summary. No quantitative metrics, comparisons, or directional changes are mentioned.

12-02-2026

LiveOne, Inc. filed an 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, balance sheet details, or other quantitative financial metrics are disclosed in the provided information. This is a multi-item filing related to financial results announcement.

12-02-2026

Farmers & Merchants Bancorp Inc filed a Form 8-K on February 12, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing summary. No period-over-period comparisons, guidance, or material impacts are mentioned.

12-02-2026

Alexandria Real Estate Equities, Inc. filed an 8-K on February 12, 2026, disclosing information under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of any financial statements or exhibits are provided in the filing summary.

12-02-2026

Olympic Steel Inc filed a Form 8-K on February 12, 2026, reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on vote outcomes, events, financial statements, or exhibits are disclosed in the provided filing summary. This is a multi-item informational filing typical after shareholder meetings.

12-02-2026

Carnival PLC filed an 8-K on February 12, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.03 material modifications to rights of security holders, with exhibits provided under Item 9.01. No specific details, financial terms, quantitative metrics, positive or negative impacts, or period-over-period comparisons are disclosed in the filing summary. This is a multi-item mandatory filing with no further transaction or impact data available.

12-02-2026

Middlefield Banc Corp filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names of individuals, reasons for the change, or any quantitative data such as compensation amounts are disclosed. Sector information is not specified.

12-02-2026

Cineverse Corp. filed a Form 8-K on 2026-02-12 reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.02 Results of Operations and Financial Condition, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, financial metrics, or period-over-period comparisons disclosed in the provided information. No positive or negative metrics are available.

12-02-2026

Origin Materials, Inc. filed a multi-item Form 8-K on February 12, 2026, reporting costs associated with exit or disposal activities under Item 2.05 alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. This indicates a material restructuring or disposal event with associated costs, which is typically negative for earnings, while Item 7.01 may provide additional voluntary context. No specific dollar values, impacts, metrics, or period-over-period comparisons are disclosed.

12-02-2026

Bain Capital Specialty Finance, Inc. filed an 8-K on February 12, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, quantitative data, period-over-period comparisons, or guidance were mentioned in the filing details provided. This appears to be a standard earnings-related disclosure without detailed performance indicators.

12-02-2026

Keurig Dr Pepper Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on affected positions, individuals involved, reasons for change, or financial impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Republic Services, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), with no specific details on the officer, position, or reason provided. The filing also covers Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), filed under AccNo: 0001060391-26-000066 (size: 540 KB). No quantitative metrics, financial impacts, or performance comparisons are mentioned.

• ·Filing AccNo: 0001060391-26-000066
• ·File Size: 540 KB
• ·Event Date: 2026-02-12
• ·Sector: NOT_DISCLOSED

12-02-2026

Helio Corp filed a Form 8-K on February 12, 2026, under Item 2.04 disclosing a triggering event that accelerates or increases a direct financial obligation or an obligation under an off-balance sheet arrangement, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. No specific details on the nature of the triggering event, dollar values, financial metrics, or other quantitative data are provided in the filing summary. This multi-item filing signals potential financial stress but lacks context on impacts.

12-02-2026

Xilio Therapeutics, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048942), disclosing under Item 1.01 entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, financial impacts, or other quantitative metrics provided in the summary. No positive or negative metrics are disclosed.

12-02-2026

Topgolf Callaway Brands Corp. filed an 8-K on February 12, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed quantitative data available.

12-02-2026

Vail Resorts Inc filed an 8-K on February 12, 2026 (AccNo: 0000812011-26-000010), reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of the Registrant), with Item 9.01 providing Financial Statements and Exhibits. No specific details on the nature of the agreement, transaction value, financial terms, or impacts are disclosed. No quantitative metrics, period-over-period comparisons, or other performance data are mentioned.

12-02-2026

Tucows Inc. (/PA/) filed an 8-K on February 12, 2026 (AccNo: 0001437749-26-003960), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No revenue, earnings, balance sheet effects, guidance, period-over-period comparisons, or other quantitative metrics are explicitly stated or available in the provided filing details. This is a multi-item informational filing typical for earnings releases.

12-02-2026

Titan International Inc filed an 8-K on February 12, 2026 (AccNo: 0000899751-26-000003), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer's name, position, reason for change, appointment or departure status, or any quantitative data are disclosed in the provided filing summary.

12-02-2026

Mueller Water Products, Inc. filed an 8-K on February 12, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific vote outcomes, numerical results, matters proposed, or other details are disclosed in the provided filing summary. This is an informational disclosure with no financial metrics or directional implications mentioned.

12-02-2026

Churchill Capital Corp X/Cayman filed an 8-K on February 12, 2026, disclosing under Item 5.07 matters submitted to a vote of security holders, Item 7.01 Regulation FD disclosure, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This multi-item filing addresses shareholder votes, material nonpublic information release, and additional events, but no specific vote outcomes, disclosure details, event descriptions, financial data, or metrics are provided. No positive or negative performance indicators, numerical values, or comparisons are mentioned.

12-02-2026

CENTERPOINT ENERGY INC filed an 8-K on February 12, 2026, under Item 8.01 reporting Other Events. No specific details regarding the nature of the events, financial impacts, transaction values, quantitative metrics, or other material information are disclosed in the provided filing summary.

12-02-2026

Coeptis Therapeutics Holdings, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, individuals involved, reasons for change, timing, or any financial metrics are disclosed. No quantitative data or period-over-period comparisons provided.

12-02-2026

FINANCIAL INSTITUTIONS INC filed an 8-K on February 12, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing represents a voluntary disclosure of material nonpublic information with attached exhibits, but no specific details, financial metrics, transactions, or performance data are provided in the filing summary. No positive or negative metrics are disclosed.

12-02-2026

Sadot Group Inc. filed a Form 8-K on 2026-02-12 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits attached under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons are disclosed. This is a multi-item mandatory disclosure of material events.

12-02-2026

NETSOL TECHNOLOGIES INC filed an 8-K on February 12, 2026, under Item 2.02 announcing results of operations and financial condition. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. Sector is not specified.

• ·AccNo: 0001493152-26-006471
• ·Filing size: 438 KB
• ·Event date: February 12, 2026

12-02-2026

Limoneira CO filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment or resignation status, reasons, timing, or any quantitative data are disclosed.

12-02-2026

Perfect Moment Ltd. filed an 8-K on February 12, 2026 (AccNo: 0001493152-26-006460), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing announcing financial results with no specific revenue, earnings, guidance, or other quantitative metrics disclosed in the provided information. Sector details are not specified.

12-02-2026

Cantor Equity Partners VI, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the filing summary. No quantitative metrics, positive or negative changes, or performance comparisons are provided.

12-02-2026

Lite Strategy, Inc. filed an 8-K on February 12, 2026, disclosing Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). Specific details including names, positions, reasons for changes, vote outcomes, or exhibit contents are NOT_DISCLOSED. No quantitative metrics, performance data, or directional implications are provided.

12-02-2026

Corebridge Financial, Inc. filed a Form 8-K on 2026-02-12 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 references financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or comparisons are disclosed.

12-02-2026

Trump Media & Technology Group Corp. filed a Form 8-K on February 12, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary provided. This is a multi-item voluntary disclosure likely including attached materials, but core details are NOT_DISCLOSED.

12-02-2026

Research Solutions, Inc. filed a Form 8-K on February 12, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, revenue, earnings, guidance, or other quantitative data were disclosed in the provided filing information. No positive or negative performance indicators, strategic transactions, or scheduled events were mentioned.

12-02-2026

12-02-2026

Nuburu, Inc. filed an 8-K on 2026-02-12 disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.01 completion of an acquisition or disposition of assets, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 3.02 unregistered sales of equity securities. While the completion of the transaction (Item 2.01) represents a key milestone, the new financial obligation (Item 2.03) and equity sales (Item 3.02) introduce potential leverage and dilution risks with no quantified impacts disclosed. No details on deal parties, structure, valuation, synergies, or shareholder impacts are provided.

• ·AccNo: 0001193125-26-049000
• ·Filing size: 161 KB
• ·Event date: 2026-02-12

12-02-2026

PTC Therapeutics, Inc. filed an 8-K on February 12, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific transactions, financial metrics, or quantitative data are disclosed in the filing summary. This appears to be a voluntary disclosure of material information with attached exhibits, but details are NOT_DISCLOSED.

12-02-2026

SafeSpace Global Corp filed a Form 8-K on February 12, 2026, specifically under Item 7.01 Regulation FD Disclosure. This single-item voluntary filing discloses material non-public information previously shared selectively, but no financial metrics, transactions, or other quantitative details are provided. No positive or negative performance indicators are mentioned.

12-02-2026

Insight Molecular Diagnostics Inc. filed an 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details, dollar values, financial impacts, or performance metrics (positive, negative, or flat) are disclosed in the provided filing summary.